A network meta-analysis of 32 randomized controlled trials revealed metformin is considered superior to hypoglycaemic drugs like insulin and glyburide in reducing respiratory distress, pregnancy-induced hypertension, macrosomia, and LGA babies, especially in obese mothers with gestational diabetes mellitus [56]. The gene discussed is INS; the disease is gestational diabetes.